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Abstract
Stem cells hold significant clinical potential to treat numerous debilitating diseases and injures that 
currently have no treatment plan. While several advances have been made in developing stem cell 
platforms and methods to induce their differentiation, there are two critical aspects need to be 
addressed: (1) efficient delivery of nucleic acids and small molecules for stem cell differentiation, 
and (2) effective, noninvasive, and real-time tracking of transplanted stem cells. To address this, 
there has been a trend of utilizing various types of nanoparticles to not only deliver biomolecules 
to targeted site but also track the location of transplanted stem cells in real time. Over the past 
decade, various types of nanoparticles, including magnetic nanoparticles, silica nanoparticles, 
quantum dots, and gold nanoparticles, have been developed to serve as vehicles for targeted 
biomolecule delivery. In addition of being biocompatible without causing adverse side effect to 
stem cells, these nanoparticles have unique chemical and physical properties that allow tracking 
and imaging in real time using different imaging instruments that are commonly found in 
hospitals. A summary of the landmark and progressive demonstrations that utilize nanoparticles 
for stem cell application is described.
INTRODUCTION
Since the last 15 years, there has been significant progress in the field of stem cell biology, 
and as a result, patients suffering from terminal diseases or traumatic injuries have new hope 
for a potential therapy.1 The field of stem cell biology and stem cell-based regenerative 
medicine has been rapidly advancing as a promising therapy to treat debilitating diseases 
and injuries caused by the loss of terminal cells.2 It is because stem cells are known for their 
potential to repair and/or replace damaged tissue.
Stem cells are undifferentiated and multipotent cells that can differentiate into specialized 
cells based on intrinsic or external cues that manipulate their genetic code.3 Differentiation 
of stem cells into specific lineages relies on expression patterns of specific genes. In normal 
human development, stem cell differentiation is innately guided by expression of intrinsic 
cues. But forced stem cell differentiation to selectively control fate requires external cues 
such as a specific microenvironment or delivery of differentiation-inducing factors.4–8
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It has long been a vision for scientists to control stem cell behavior and fate as required for 
various clinical applications, and several methods to externally regulate stem cell fate have 
been developed. The long-term goal is to harvest stem cells from patients, and through the 
use of various external cues, to generate specialized cells for implantation back into the 
patients. Even though progress has been made, the use of conventional methods to induce 
differentiation, such as viral vectors, DNA plasmids, small molecules, and a combination of 
thereof, has specific limitations. Hence, researchers have been exploring alternatives, and as 
a result, the field of nanotechnology has significantly advanced for biological applications.
Nanotechnology has recently emerged as an exciting field of research involving the use of 
nanoscale materials for various applications including stem cell biology. Because of the 
extremely small scale of nanotechnology, ranging from 1 to 1000 nm, the potential of 
nanotechnology-based applications appears limitless. Researchers from multidisciplinary 
fields have integrated expertise from inorganic chemistry, organic chemistry, material 
science, engineering, and stem cell biology to develop various nanoplatforms and devices for 
manipulating stem cell behavior.9 In fact, over the past 10 years, the number of publications 
involving nanotechnology and stem cell biology has grown exponentially. This is because of 
the great potential that stems from its amazing intrinsic qualities and widespread application 
potential.
There are two primary modes through which nanotechnology can regulate stem cell fate: (1) 
fabrication of nanoscale surfaces to mimic the various natural three-dimensional (3D) 
microenvironment of cells and (2) delivery of nanoscale materials to selectively target 
intracellular pathways.9,10 The cellular microenvironment in the body is a 3D dynamic 
process that cannot be effectively replicated in the traditional cell culture dishes. However, 
various nanoscale scaffolds and nanopatterned substrates with variable surface roughness 
and porosity have been fabricated to more effectively replicate the in vivo niche.11 As a 
result, this not only provides insight into mechanistic studies to probe stem cell signaling 
pathways that induce differentiation but also a novel method to induce differentiation by 
mimicking the microenvironment.12 Moreover, in an alternative approach, researchers have 
developed nanomaterials that can be used as intracellular deliver vehicles to introduce 
specific small molecules and biomolecules into cells. The small molecules that are delivered 
can selectively activate and regulate specific signaling pathways in stem cells to induce 
targeted differentiation. These nanomaterials can be of different shapes, sizes, and 
compositions, and thus they can be tuned for specific applications.
While several types of nanomaterials have been developed as deliver agents, the most 
prominent and widely used are nanoparticles. Nanoparticles are small, spherical materials 
that can range in size from 2 to 500 nm, and the most widely used types of inorganic 
nanoparticles include magnetic nanoparticles (MNPs), gold nanoparticles, silica 
nanoparticles (SNPs), and quantum dots (QDs) (Figure 1). Each of these nanoparticles not 
only have the ability to carry specific small molecules into the cells but also have 
multifunctional properties such as contrast imaging, surface porosity, and magnetic 
capabilities for a synergistic effect to track and regulate stem cell behavior. Moreover, these 
nanoparticles are generally biocompatible with minimal side effect or cytotoxicity, thus 
allowing them to be used as safe delivery agents.13 Because certain compositions of gold 
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nanoparticles and MNPs have been approved by the FDA for clinical applications, there is a 
surge of using these nanoparticles for stem cell differentiation with potential for translation 
into the clinic.14
NANOPARTICLE UPTAKE MECHANISM
The first step for utilizing nanoparticle-based delivery of small molecules and exploiting 
their multifunctional properties for stem cell application involves efficient uptake of 
nanoparticles into the cell.15 Stem cells tightly regulate movement of cargo through the 
plasma membrane, and hence, a major challenge is the efficient intracellular uptake of 
nanoparticles. Because nanoparticles are comprised of inorganic compounds, the cell does 
not readily allow them to enter. However, the cell has an endocytosis mechanism to allow 
large substances and cargo, such as nanoparticles, to enter the cell.16 Endocytosis is an 
energy-dependent process by which cells engulf substances on the cell surface and shuttle 
them into the cytoplasm. Specifically, as the nanoparticles near the surface of the cells, they 
can bind to the cell surface receptors—if the nanoparticle is functionalized with such 
binding moieties—which signals the cell to change the conformation of the plasma 
membrane by forming a cavity through which the nanoparticles can enter. Then the plasma 
membrane cavity completely engulfs the nanoparticle and enters the cytoplasm. This process 
of endocytosis is ubiquitous for almost all adherent cell types. Endocytosis is divided into 
four categories with slightly different mechanisms to shuttle different-sized foreign 
substances into the cell: clathrin-mediated endocytosis, caveolae, micropinocytosis, and 
phagocytosis. Depending on the size and surface makers of the nanoparticle, one of these 
mechanisms allows nanoparticle uptake into the cell17,18 (Figure 2).
To facilitate the process of nanoparticle endocytosis, it is critical for nanoparticles to be 
functionalized with surface ligands that can bind to specific cell surface receptors. Cellular 
uptake dynamics for nanoparticle uptake is greatly dependent on the size of the nanoparticle 
and the peptides present on the surface.19 Cell-penetrating peptides are a class of peptides 
that are specifically designed and conjugated on nanoparticles to enable plasma membrane 
penetration.17,20 With the use of cell-penetrating peptides and nuclear localization signal 
peptides, it is possible to engineer nanoparticles to not only cross the plasma membrane but 
also the nuclear membrane to gain entry inside the nucleus.21,22 Moreover, the size of 
nanoparticles has been demonstrated to play a significant role in both plasma membrane and 
nuclear membrane uptake. Studies have shown that nanoparticles ranging from 10 to 100 nm 
can enter the cell, with an optimal nanoparticle diameter of 50 nm for maximum uptake.23 
Therefore, depending on the application, the size of the nanoparticles must be optimized. 
Furthermore, the chemical properties of ligands present on the nanoparticle surface also play 
a critical role in cellular uptake. Properties such as solubility, pH, and hydrophobicity 
influence cellular uptake.24,25
When nanoparticles are incubated in biological fluid, such as cell culture media, proteins 
bind to the ligands on the nanoparticle surface to form what is called a protein corona, which 
can critically influence the interaction of nanoparticles with cells.26 The protein corona has 
been recently demonstrated to play a striking role in nanoparticle uptake.27 The concept of 
protein corona suggests that the mix of over 300 proteins, which are found in serum-
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containing culture media, rapidly adsorbs on the nanoparticle surface within a few minutes, 
and the interaction of these proteins with the cell surface enables uptake.28,29 Even though 
several membrane-penetrating peptides have been developed and demonstrated to be 
efficient, the formation of the protein corona and its exact mechanism, which is still unclear, 
may play a significant role.
MAGNETIC NANOPARTICLES IN STEM CELL BIOLOGY
Magnetic nanoparticles (MNPs) are a class of nanoparticles, comprised of magnetic 
materials such as iron, cobalt, nickel, and zinc, which can be manipulated with a magnetic 
field.30 MNPs are spherical in shape and range in size from 10 to 100 nm, and their 
composition can have a mixture of various metals, such as Fe3O4, Fe2O3, NiFe2O4, and 
FeCo, that result in different magnetic properties.31 MNPs have desirable physiochemical 
properties, biological inertness, high stability in physiological conditions, and excellent 
magnetic properties that allow for noninvasive imaging and enhanced cellular uptake, thus 
establishing MNPs as excellent carriers of small molecules and biomolecules.32,33 The 
primary advantage of MNPs is their unique magnetic properties, and therefore, researchers 
have exploited these features by employing MNPs for three specific applications in stem cell 
biology: (1) enhanced delivery owing to magnetofection (magnet-facilitated delivery),34 (2) 
stem cell tracking using various imaging techniques,35,36 and (3) magnetically guiding stem 
cells to targeted sites in vivo.
Magnetically Facilitated Delivery for Enhanced Stem Cell Differentiation
Traditional methods to deliver MNPS typically require cell-penetrating peptides present on 
the nanoparticle surface or transfection reagents; but increasing the transfection efficiency so 
that more MNPs enter the cell without compromising viability is a challenge. The unique 
magnetic properties of MNP enable enhanced delivery owing to magnetofection, a technique 
that involves incubating MNPs in cell culture and placing a magnet underneath to generate a 
magnetic field that ‘pulls down’ the MNPs onto the cell surface.34,37 As a result, 
significantly more MNPs enter the cell and cell viability is not compromised through this 
process.
Recently, Lee and coworkers used a magnetofection-based approach to efficiently delivery 
MNPs into neural stem cells (NSCs) to induce neuronal differentiation.38 They used zinc-
doped MNPs, ZnFe2O4, as a core and synthesized a gold shell to develop a magnetic core–
shell nanoparticle (MCNP) (Figure 3(a)–(c)). The purpose of the outer gold shell is to 
increase biocompatibility, enable multiple biomolecules to anchor onto a single nanoparticle, 
and prevent free radical formation from the MNP core. Specifically, the MCNPs were 
functionalized with a linker molecule to increase water solubility. Then the polyamine was 
coated to make the surface positively charged and then a small-molecule nucleic acid called 
siRNA, which represses gene expression, was electrostatically conjugated on the surface 
(Figure 3(a)). First, delivery properties were tested using magnetofection, which revealed 
that green fluorescent protein (GFP)-labeled NSCs exposed to a magnet for just 30 min 
significantly increased the transfection efficiency. Moreover, magnetofection-based delivery 
of MCNP showed a remarkable downregulation in GFP when compared with MCNPs 
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delivered using conventional methods (Figure 3(d)). Then the MCNP was utilized for the 
delivery of siRNA to control neuronal differentiation of NSCs, which revealed that NSCs 
can be selectively differentiated to either neurons or oligodendrocytes in an efficient and 
nontoxic manner (Figure 3(e) and (f)). Furthermore, the gold shell enabled dark-field 
imaging to confirm the presence of MCNPs inside the NSCs. This was the very first 
demonstration to show the utilization of MNPs for the delivery of small molecules into stem 
cells to induce differentiation.
MNPs for Stem Cell Labeling and Tracking
The second utilization of MNPs for stem cell-based application is stem cell tracking. The 
end goal for any stem cell-based research is successful transplantation into diseased or 
injured patients for regeneration. For this, one important criterion is to track the location of 
the cells after transplantation, ideally in a safe and noninvasive manner. For this purpose, 
MNPs can be used for stem cell-based therapies to track stem cell migration and localization 
in vivo because of their unique magnetic properties that enable imaging techniques such as 
magnetic resonance imaging (MRI).39 Among the available in vivo imaging techniques 
applicable for stem cell monitoring, MRI is particularly promising because it can provide 
high spatial resolution without compromising the patient’s care. Stem cells, especially, 
mesenchymal stem cells (MSCs), have been increasingly utilized for in vivo transplantation, 
and it is highly desired to track the location of these transplanted MSC in real time.40–42 For 
this purpose, MNPs can be loaded into MSCs before transplantation, and their location can 
be imaged in real time using MRI. For example, rat MSCs (rMSCs) secreting neurotrophic 
factors were labeled with MNPs and transplanted into Huntington’s disease rat models.43 
After 18 days, the animals were sacrificed and their brains were imaged to access the 
migratory path of the transplanted cells. High-resolution 2D and 3D MRI revealed that the 
transplanted cells migrated along a distant route toward the lesioned site (Figure 4). This 
confirmed that MSCs can not only seek lesioned regions in vivo but also that MNP-labeled 
cells can be tracked via noninvasive MRI even 18 days post-transplantation. On the basis of 
this study, it is evident that MNPs are an invaluable tool for tracking stem cells.
In another exciting application of MNPs for monitoring stem cell migration in vivo, NSCs 
were extracted from patients suffering from traumatic brain injury, and these NSCs were 
labeled with MNPs.44 Then, approximately 50,000 of these MNP-labeled NSCs were 
transplanted into the brain injury site. By utilizing MRI over a 10-week period, the 
progression and migration of the MNP-labeled NSCs was tracked, and reveled migration 
from the injection sites to white and gray matter. This phenomenon was not observed in 
patients who received unlabeled cells. Furthermore, it was confirmed that the magnetic 
signal was indeed from the MNP-labeled NSCs, and not macrophages that engulfed the 
NSCs, through double fluorescent imaging. It is evident that MNPs are great contrast agents 
for real-time imaging for stem cell therapies; however, there is one drawback that needs to 
be addressed. MNP-labeled cells transplanted into the body may not discriminate between 
labeled dead and live cells. Therefore, if the MNP-labeled cells die after being transplanted, 
the signal from the MNPs inside the cells will still persist. To test this effect, mice were 
transplanted with MNP-labeled MSCs and MNP-labeled dead MSCs in the spinal cord, and 
after 6 weeks, MRI detected a persistent signal from both conditions.45 This implies that 
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even if cells can be tracked in vivo using MNPs and MRI, an alternative method such as 
fluorescence imaging has to be utilized to confirm the viability of transplanted cells.
Externally Guiding Transplanted Stem Cells to the Target Site In Vivo
Even after stem cells are transplanted in vivo, there is no guarantee that they migrate or 
localize to the area of the diseased or injured site. This limits the full potential of stem cell 
for regenerative medicine application in vivo. Hence, researchers are exploiting the magnetic 
properties of MNPs to selectively and exogenously guide transplanted stem cells to the 
lesioned site where stem cells are required. For example, in one recent study, MNPs were 
coated with a polyethylene glycol to increase biocompatibility and delivered to human 
MSCs (hMSCs).46 Then it was confirmed that these MNPs localize in the hMSC lysosomes 
and are not toxic to cells for a prolonged period. Then they tested the response of MNP-
loaded hMSCs under both static and nonstatic conditions. Under static conditions, the MNP-
loaded hMSCs were plated over an array of magnets for 4 h, which caused the cells to 
accumulate in the sites with the highest magnetic gradient (Figure 5(a)). Using mathematical 
models to mimic the bloodstream, the response of hMSCs was tested, and revealed that 
MNPs accumulated in the region of highest magnetic strength (Figure 5(b)). More 
interestingly, the MNP-loaded hMSCs were injected into the tail vein of mice, with a magnet 
placed on the proximal portion, which resulted in over a sixfold increase of accumulation of 
hMSCs in the tail (Figure 5(c)). This result has immense implications for in vivo 
experiments because transplanted cells loaded with MNPs can now be guided to the target 
site using external, noninvasive methods such as a magnet. Stem cell transplantation for 
regenerative medicine is a highly promising and pursued field of research, and MNPs 
provide an effective and noninvasive method to track their progression and precise location 
in vivo.
SILICA NANOPARTICLES IN STEM CELL BIOLOGY
Silica nanoparticles (SNPs) are a class of nanoparticles comprised of SiO2 and are used 
extensively for biomedical applications.47 Their inert properties, small and tunable 
diameters, and biofunctional capabilities make SNPs an attractive nanomaterial for 
biological applications. In fact, in 2011, an investigational new drug application for 
exploring SNPs for targeted molecular imaging was approved by the US Food and Drug 
Administration for an in-human clinical trial, thus highlighting SNPs as an effective 
platform with potential for clinical translation.48
SNPs can be categorized into two major categories: nonporous (solid) SNPs and mesoporous 
SNPs. Nonporous SNPs are solid, smooth nanoparticles and deliver biomolecule cargo 
through encapsulation within the SNP or through conjugation of biomolecules on the 
surface.49 On the other hand, mesoporous SNPs contain numerous pores (2–50 nm in size) 
on the surface that can hold biomolecule payloads for delivery.50 The pores are ‘capped’ 
with a gatekeeper molecule which functions to prevent the release of the payload until the 
gatekeeper molecule is degraded by intracellular enzymes or opened through external stimuli 
signals that alter the molecule conformation, thus allowing controlled release of biomolecule 
payload.50 The release profile of nonporous SNPs is controlled by the linker molecules or 
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degradation of the silica matrix. Nonporous SNPs can be synthesized in various sizes and 
the pore size in mesoporous SNPs can be easily tuned based on the synthetic protocol. Both 
nonporous and mesoporous SNPs have found their niche in stem cell biology for various 
applications including stem cell differentiation, stem cell imaging, and in vivo real-time 
stem cell tracking.
Nonporous SNPs for Stem Cell Imaging and Differentiation
Nonporous SNPs have a great multifunctional surface that enables conjugation of active 
biomolecules for delivery into stem cells.51 As a result, SNPs have been demonstrated to 
deliver differentiation-specific molecules into stem cells for inducing differentiation and 
conversion into desired lineages. In one demonstration, SNPs were functionalized with 
insulin and delivered to rMSCs to induce adipogenic differentiation.52 Specifically, 
researchers first showed a systemic study confirming the biocompatibility of the SNPs with 
rMSCs that revealed high biocompatibility. Furthermore, high-resolution imaging showed 
that internalization of SNPs by rMSCs had no effect on the cellular structure of organelles. 
When the SNP–insulin conjugates were delivered to rMSCs, successful differentiation into 
adipogenic tissue was observed, thus demonstrating that the biological activity of insulin 
was not affected by conjugation to SNP. Hence, SNPs can be established as effective 
biocompatible carriers of molecules to induce stem cell differentiation. Furthermore, this 
result is in conjunction with other studies showing that SNPs are safe for prolonged 
internalization inside the cells.53,54
In addition to their multifunctional surface capable to delivering biomolecules into stem 
cells, SNPs have unique intrinsic properties that make them especially attractive for stem 
cell transplantation applications. SNPs can be detected and visualized using ultrasound 
owing to their high impedance mismatch.55 Ultrasound is a promising tool for stem cell 
therapy because of its high resolution, low cost, and high depth penetration. Moreover, 
ultrasound is readily available to clinicians and easy to use, thus making it applicable for 
stem cell tracking after implantation. One landmark demonstration using ultrasound and 
SNPs for live stem cell tracking showed the effectiveness of this technique, wherein 
researchers encapsulated 300 nm SNPs with a fluorescent dye and the element gadolinium to 
enhance MRI contrast and ultrasound imaging56 (Figure 6(a)). These SNPs were then 
delivered to hMSCs, and imaging showed intracellular aggregation of SNP, which actually 
enhanced the ultrasound signal without influencing cell behavior or metabolism. The SNP-
loaded hMSCs made them applicable for cell sorting through their fluorescence signal. The 
SNP-loaded hMSCs were then transplanted into mouse model via injections, and after only 
11 seconds, researchers were able to use ultrasound imaging to identify the exact location of 
cells and assess the possibility of a misinjection (Figure 6(b)). Furthermore, MRI was 
utilized after the ultrasound-guided delivery of SNP-loaded hMSCs into mouse cardiac 
tissue. Compared with traditional methods, the SNP loading increased the ultrasound and 
MRI contrast of labeled hMSCs by over 700 and 200%, respectively. Even after 13 days of 
implantation, the ultrasound signal and MRI contrast could still detect and identify the 
location of the transplanted hMSCs (Figure 6(c)). Lastly, researchers performed a series of 
experiments to evaluate the impact of SNPs on hMSCs, and found that all cellular functions, 
including proliferation, cytokine expression, and metabolic activity, were unaffected. 
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Overall, the use of nonporous SNPs for stem cell tracking and stem cell differentiation is a 
highly promising area of research with potential for translation into the clinic.
Mesoporous SNPs for Delivery of Differentiation-Specific Factors to Stem Cells
The second class of SNPs are mesoporous SNPs, which have pores on the surface in which 
biomolecules can be embedded and later released into the cell. Taking advantage of this 
unique feature, researchers demonstrated that differentiation-specific biomolecules can be 
loaded in the pores to induce stem cell differentiation.57 Bone morphogenetic proteins 
(BMPs) are factors that can induce osteogenic bone differentiation. Researchers embedded 
BMPs into mesoporous SNPs and delivered them into adipose-derived MSCs, with the goal 
that after the cells uptake the mesoporous SNPs, BMPs would be released from the pores to 
induce differentiation. Histological staining revealed successful osteogenic differentiation in 
a highly efficient manner. Comparatively, control studies with BMPs delivered without 
mesoporous SNPs showed minimal differentiation.
Generally, stem cells are extremely sensitive to intracellular introduction of foreign 
inorganic matter, especially embryonic stem cells (ESCs). Just the presence of inorganic 
matter causes the stimulus of unwanted signaling pathways that can disrupt normal cells 
function and differentiation capacity. But a research group recently demonstrated that 
delivery of peptides using mesoporous SNPs does not have any adverse side effects on ESCs 
and, instead, promotes targeted differentiation.58 The mesoporous SNPs were loaded with 
two peptides, Cintrofin and Gliafin. Cintrofin has been shown to induce neuronal 
differentiation and promote survival, while Gliafin has been shown to promote neurite 
outgrowth. When these two peptides were loaded into mesoporous and delivered into ESC-
derived motor neuron (MN) precursor cells, differentiation into MNs that exhibit neurite 
branching was observed. Moreover, these induced MNs displayed electrophysiological 
properties with a resting membrane potential close to the physiological range that would be 
driven to high spiking frequencies. Then, these ESCs were loaded with mesoporous SNPs 
and transplanted into mice models for in vivo differentiation and integration into the mice 
neural network. After 2 weeks, the condition with loaded mesoporous SNPs showed a 
neurite outgrowth and the volume of cells was almost 10 times larger than control conditions 
that lacked SNP and peptides. After 2 months, the condition with mesoporous SNP-loaded 
ESCs showed extensive neurite arborizations and expression of prominent markers such as 
choline acetyltransferase (ChAT), while control conditions showed minimal expression. 
Taken together, these results suggest that co-transplantation of ESCs loaded with 
mesoporous SNPs can increase transplant size, improve survival, and induce neurite 
outgrowth.
The development of induced pluripotent stem cells (iPSCs) as a robust source of embryonic-
like cells, with the ability to differentiate into almost any cell type, has opened the door for 
stem cell therapies with potential clinical translation. The first ever demonstration of using 
SNPs with iPSCs was reported in 2013, wherein researchers evaluated the sensitivity of 
iPSCs to SNPs and the differentiation capacity of iPSCs transfected with DNA-loaded SNPs 
(Figure 7(a)).59 First, because iPSCs are difficult to transfect and are extremely sensitive to 
foreign inorganic matter, the uptake dynamics of mesoporous SNP was evaluated. Three 
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types of mesoporous SNPs were tested, positively charged, negatively charged, and neutral, 
and the response to iPSCs was carefully observed and resulted in the identification that 
positively charged mesoporous SNPs were more efficiently internalized by the iPSCs 
(Figure 7(b)). Next, to ensure that the intracellular presence of mesoporous SNPs in iPSCs 
did not impair their function, metabolism, and differentiation capacity of iPSCs, various 
experiments were performed and showed that cell proliferation, pluripotency, and in vivo 
teratoma formation were not affected. In the final experiment, the mesoporous SNPs were 
loaded with an HNF3β-plasmid-DNA, which has been shown to induce hepatocyte 
differentiation. The iPSCs transfected with these mesoporous SNPs loaded with HNF3β 
exhibited successful differentiation into functional hepatocyte-like cells (Figure 7(c)). These 
results not only demonstrate the potential for stem cell labeling using mesoporous SNPs but 
also that they can act as efficient carriers of differentiation-specific biomolecules into 
sensitive cells such as iPSCs and induce their differentiation.
Hybrid Silica–MNPs Enhance Stem Cell Tracking
SNP and mesoporous SNPs have a unique chemical and synthetic property of being able to 
integrate with other types of metallic nanoparticle compositions such as gold and iron oxide.
42
 These hybrid SNPs are fabricated with a gold shell and a SNP core, or SNPs can act as a 
shell around magnetic iron oxide nanoparticle cores.60 The added benefit of these hybrid 
SNPs has a synergistic effect in terms of biomolecule loading and contract imaging. A 
landmark study demonstrated the feasibility of incorporating a magnetic iron oxide 
nanoparticle inside SNPs for synergistic stem cell labeling. These hybrid SNPs were 50 nm 
in diameter, and when they are delivered to hMSCs, sufficient MRI is achieved.61 
Furthermore, when these loaded hMSCs are transplanted into mouse model, MRI can also 
detect their presence. Moreover, the differentiation capacity, proliferation, and viability of 
loaded hMSCs remain unaffected. Hybrid SNPs can have a big impact on translational 
medicine because of their biological inertness and synergistic modalities.
QUANTUM DOTS IN STEM CELL BIOLOGY
Quantum dots (QDs) are a class of multifunctional, fluorescent semiconductor nanoparticles 
that exhibit quantum mechanical properties of intrinsic emission profiles.62 QDs vary in size 
from 2 to 50 nm, and the emission properties of QDs are directly correlated to either the size 
or chemical composition (Figure 8(a)). QDs have a broad excitation spectra and a narrow 
emission spectra. The QDs emit certain wavelengths of fluorescent light, and thus are 
excellent nanomaterials for noninvasive in vivo imaging and stem cell tracking.63 Because 
QDs are excited by a single UV light source and can emit different wavelengths of 
fluorescent light, they are ideal tools for multiplex imaging.64 Moreover, QDs are extremely 
resistant to photobleaching, meaning that they retain emission intensity and brightness, even 
after long exposure times, and thus are excellent alternative to traditional molecular dyes to 
imaging applications. In recent years, the unique and photophysical properties have enabled 
researchers to broaden the application scope of QDs for stem cell applications because QDs 
have a multifunctional surface, which, in addition to fluorescent imaging, allows them to 
simultaneously deliver functional biomolecules. This combinatorial advantage of QDs has 
propelled them for stem cell applications.
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QDs for ESCs Labeling
The most prominent stem cells with the highest in vivo potential are ESCs because of their 
wide differentiation capacity. Therefore, the number of stem cell transplantation studies 
involving ESCs has been increasing. One important criteria of implantation is to track the 
location of transplanted ESCs. For this purpose, QDs have emerged as promising probes of 
stem cell labeling and imaging. But before utilizing QDs for stem cell application, it is 
critical to evaluate the effect and influence that QDs may have on stem cells, because stem 
cell are generally sensitive to foreign matter and can alter their metabolism which can 
adversely impact their differentiation capacity. Furthermore, traditional QDs are synthesized 
using toxic elements such as cadmium (Cd)- and selenide (Se)-based core, which can 
damage the cell even at low concentrations. However, the use of a ZnS shell prevents the 
release of the toxic Cd elements, thereby circumventing the cytotoxicity issue.65 Therefore, 
it is important to test the effects of QDs on stem cells. For this purpose, researchers tested 
the behavior and pluripotent characteristics of ESCs and kidney stem cells when delivered 
with QDs.66 Results indicate that the native pluripotency markers of ESCs such as Oct4, the 
proliferation rate, and the viability of ESCs are unchanged by the presence of QDs (Figure 
8(b)). The differentiation capacity was also not influenced as QD-labeled ESCs were able to 
effectively differentiate into the three germ layers, endoderm, ectoderm, and mesoderm, with 
the genetic expression of lineage-specific being identical to differentiated ESCs lacking QDs 
(Figure 8(c) and (d)). Then, to confirm that the labeled ESCs did not excrete the QDs, which 
could potentially be uptaken by adjacent cells, fluorescent imaging revealed that ESCs do 
not excrete the QDs and that transfer of QDs in co-cultures was minimal (Figure 8(e)–(g)). 
Finally, it was determined that even if the ESCs die in culture, the QDs within are also not 
readily uptaken by adjacent cells. Hence, on the basis of these results, we can deduce that 
QDs are relatively safe for stem cell applications with minimal side effects.
In another demonstration, researchers sought to evaluate the effect of QDs on ESC behaviors 
and the feasibility of using QD-labeled ESCs for transplantation studies.67 To ensure that the 
pluripotency properties of ESCs were not affected by the presence of QDs, they delivered 
the QDs to ESCs and tested pluripotency markers such as Oct4, and found that expression of 
these markers remained unchanged. Thus, QDs were established as safe agents for further 
ESC studies. Then, six different types of QDs were delivered to ESCs, and these QD-labeled 
ESCs were injected into the backs of nude mice (Figure 9(a)). Fluorescent imaging revealed 
that using just a single UV light source, the emission from the six QD-labeled ESCs can be 
individually detected simultaneously. Finally, to test the prospects of utilizing QDs for long-
term stem cell tracking, different amounts of QD-labeled ESCs were injected into nude mice 
and successive imaging was performed for several weeks, which showed that QDs emit a 
strong and detectable signal even 14 days postinjection (Figure 9(b) and (c)). This study 
opened the door for the use of QDs in stem cell research. For example, in another 
demonstration, bone-derived stem cells (BDSCs) were labeled with QDs and were injected 
into the retina to repair retinal injury.68 After transplantation, the location of the injected 
stem cells could be tracked using fluorescent imaging.
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Nontoxic Alternative QDs for Stem Cell Biology
Combining different types of nanoparticles is an interesting subset of research because it 
includes the advantageous features from both nanoparticles on a single construct. 
Furthermore, it is desirable to coat QDs with a specific type of nanomaterial to prevent 
leeching of the toxic CdSe core. For this purpose, a recent demonstration showed that QDs 
can be coated with SNPs and still retain its fluorescence properties.69 A strong intracellular 
fluorescence signal confirmed that the QDs were effectively uptaken and were able to emit 
its signal. Moreover, it was determined that a 4-h incubation time is the optimal time for 
maximal uptake of QDs in stem cells.
Another class of recently developed QDs is called graphene quantum dots (GQDs), which 
are comprised of nanosized graphene sheets and have intrinsic fluorescent properties.70 
Graphene is a lattice of sp2-carbon sheets that has attracted significant attention owing to its 
unique properties and vast potential for application in almost every field of research. When 
these graphene sheets are layered together, nanosized GNPs can be created. The most 
interesting feature of GQDs is their ability to fluoresce under a UV light source. Taking 
advantage of this, researchers recently developed a facile approach to synthesize large 
quantities of GQDs that are suitable for stem cell applications.71 Specifically, GQDs were 
used to label various types of cells including neurosphere cells, pancreas progenitor cells, 
and cardiac progenitor cells, in an effective manner without any cytotoxicity.
Lastly, conventional QDs are comprised of CdSe, which is quite toxic cells, and hence they 
are capped with an inert ZnS shell to prevent leaching of Cd or Se into the cells. However, it 
would be highly desirable to replace these toxic elements altogether and use inert elements 
while preserving the fluorescence properties of QDs. To this end, researchers have 
developed a unique and facile method to synthesize QDs comprised of nontoxic elements 
using a sonochemical approach.72 Specifically, QDs comprised of zinc, indium, silver, and 
sulfur (ZAIS-QDs) have been developed, which were demonstrated to be nontoxic to stem 
cells (Figure 10(a)). Moreover, the most attractive feature of ZAIS-QDs is that the emission 
profile can be tuned based exclusively on the composition of these starting elements (Figure 
10(b)). Hence, a large-scale library of ZAIS-QDs was readily synthesized and subsequently 
transfected into hMSCs with high viability, and showed efficient uptake with a strong 
fluorescent signal (Figure 10(c) and (d)). Moreover, the ZAIS-QDs were functionalized with 
a nucleic acid for simultaneous gene regulation, thus demonstrating the multifaceted 
properties of QDs.
NANOPARTICLE ARRAYS FOR STEM CELL BIOLOGY
The ability to use physical cues such as nanotopo-graphical cues, substrate patterns, and 
extracellular matrix (ECM) geometries to control stem cell fate is a highly promising area of 
research.11,73,74 While most techniques discussed thus far have focused on the delivery of 
nanoparticles, there is another application of nanoparticles involving surface topography. 
Instead of conjugating biomolecules onto nanoparticles for a forward transfection, a recently 
developed method involves fabricating an array of nanoparticles and then culturing stem 
cells directly on these nanoparticles. The physical topographical cues and the microsurface 
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created by the nanoparticles can act to deliver biomolecules and to induce targeted 
differentiation and behavioral changes of stem cells.75
Nanoparticle Arrays to Deliver Nucleic Acids for Stem Cell Differentiation
In a recent landmark demonstration, researchers utilized a nanoparticle array to deliver hard-
to-transfect biomolecules such as small interfering RNA (siRNA), which effectively regulate 
gene expression, into NSCs to induce neuronal differentiation.76 SNP sizes varying from 
100 to 700 nm in diameter were assembled on a glass substrate using a facile centrifugation 
method to fabricate the nanotopography-mediated reverse uptake (NanoRU) platform 
(Figure 11(a)). Then, siRNA molecules were electrostatically conjugated on NanoRU. When 
NSCs were seeded on these substrates, NSCs readily attached to the surface and extended 
their axons (Figure 11(b)). To test the efficiency, GFP-labeled NSCs were seeded on 
NanoRU that was conjugated with siRNA specific for GFP. The results showed a remarkable 
trend of GFP knockdown as the size of the substrate nanoparticles became smaller, with 100 
nm SNPs having the greatest GFP knockdown (Figure 11(c)). Thereafter, siRNA specific for 
the Sox9 gene, which is responsible for regulating neuronal differentiation, was conjugated 
on NanoRU and NSCs were seeded on top. The NSCs readily took up the siRNA, and after 
just 7 days, successful neuronal differentiation was induced (Figure 11(d) and (e)). The 
NanoRU platform was then compared to traditional methods of siRNA delivery such as 
commercially available reagents including Lipofectamine. NanoRU was more efficient and 
resulted in a significantly higher cell viability. Overall, the researchers concluded that based 
exclusively on the nanotopography created by the nanoparticle array, nucleic acids could 
easy be transfected into stem cells to regulate their differentiation.
Nanoparticle Arrays to Regulate Neuronal Behaviors of Stem Cells
In another study, the same authors modified the nanotopography by incorporating a sheet of 
graphene oxide on the surface of NanoRU to differentiate neural progenitor stem cells 
(hNPSCs)77 (Figure 12(a)). Remarkably, just owing to the influence of the surface, the axons 
of the hNPSCs started to align (Figure 12(b)–(d)). The degree of alignment and efficiency of 
neuronal differentiation were the highest when hNPSCs were seeded on a surface containing 
both SNPs and graphene oxide (Figure 12(e)). Furthermore, the results were reproduced on a 
flexible polymer, which can potentially be used for in vivo applications (Figure 12(f)). 
Results show a similar trend of axonal alignment and increase differentiation. Conventional 
nanoparticle-based methods directly conjugate biomolecules on nanoparticle surfaces for 
forward delivery, but the method of generating a biocompatible platform for stem cells to 
grow is a promising approach because biomolecules are readily uptaken with a synergistic 
effect of nanotopographical cues to guide stem cell differentiation.
CONCLUSIONS AND FUTURE OUTLOOK
Nanoparticles represent a powerful and innovate class of materials for applications in stem 
cell biology ranging from small molecule delivery, imaging, and in vivo tracking. The field 
of nanotechnology and nanomedicine has made significant strides over the past decade, and 
now, several promising approaches are reaching in vivo and clinical therapies. In order to 
effectively use nanoparticles for stem cell applications, there are three requirements: high 
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biocompatibility, a multifunctional surface to enable conjugation of biomolecules, and 
properties to enable noninvasive imaging. To this end, many different types of nanoparticle 
have been developed for stem cell applications including MNPs, SNPs, QDs, and hybrid 
nanoparticles that integrate multiple nanoparticles together. Each of these nanoparticles has 
its own unique properties in terms of size, composition, biocompatibility, imaging 
capabilities, and possible side effects.
A majority of applications utilizing nanoparticles involve stem cell labeling and stem cell 
tracking in vivo. This is because nanoparticles have excellent intrinsic chemical and physical 
properties that allow efficient imaging after transplantation without any adverse side effects 
on cells or patients. Perhaps, the greatest feature that enables this is their small size, which 
allows them to remain inside the cells without causing any cellular damage. Furthermore, 
there is another scope of application of nanoparticles that involves delivery of nucleic acids 
and small molecules, which are otherwise difficult to deliver, into stem cells for 
differentiation. This opens up the door to test almost any type of molecule, regardless if its 
physical and chemical properties are not suitable for physiological environments. 
Furthermore, targeted delivery into specific intracellular organelles is achievable by adding 
targeting peptides on the nanoparticle surface. With all these advantages of nanoparticles, 
stem cell biologists and clinicians have the ability to choose the proper nanoparticle for their 
specific application.
The major obstacle that is currently hindering widespread use of nanoparticle for clinical 
stem cell use is the possibility of nanoparticles accumulating in organs and the possible side 
effects. Even though the nanoparticles may be biocompatible, the effect of accumulating 
nanoparticles in specific organs after transplanting nanoparticles-loaded stem cells needs to 
be addressed. With the recent development of hybrid nanoparticles that have a synergistic 
and combinatorial effect in terms on delivery and imaging, the development of safer 
nanoparticles appears promising. The future of utilizing nanoparticles for stem cell-based 
applications and clinical therapies is very bright. With a greater push for stem cell therapies 
to treat numerous debilitating diseases and injuries, more resources are now geared toward 
developing translational nanoparticle-based platforms for stem cell medicine.
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FIGURE 1. 
Designing nanoparticles for stem cell applications. The physical properties of nanoparticles 
can be selectively designed for specific applications based on the material composition and 
physical properties. Nanoparticles can be made functionally active depending on the surface 
chemistry and the functional biomolecules. Nanoparticles are highly tunable and have a 
modular chemistry, thus enabling their application for desired stem cell applications. 
(Reprinted with permission from Ref 15. Copyright 2011 Royal Society of Chemistry)
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FIGURE 2. 
Cellular uptake mechanisms. Cells have various energy-dependent mechanisms for allowing 
extracellular cargo inside. Depending on the size of the cargo, processes such as caveolae 
mechanism are induced for small cargo, clathrin mechanism for intermediate cargo, and 
macropinocytosis for large cargo, are utilized by the cell. Because nanoparticles can vary in 
size ranging from 5 to 500 nm, different mechanisms are utilized by the cell to enable 
nanoparticle entry. (Reprinted with permission from Ref 17. Copyright 2014 American 
Chemical Society)
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FIGURE 3. 
Magnetic core–shell nanoparticles (MCNPs) for stem cell differentiation and imaging. (a) 
Schematic of MCNPs functionalized with mercaptoundecanoic acid (MUA) followed by 
electrostatic conjugation of polyamide and nucleic acids for regulating gene expression in 
stem cells. (b) A representative image showing that MCNPs with a composition of ZnFe2O4 
are attracted to a magnet. (c) TEM image of MCNPs (scale bar = 10 nm). (d) MCNPs were 
incubated in green fluorescent protein (GFP)-labeled rat neural stem cells (rNSCs) and 
exposed to magnetofection (MF). The resulting GFP knockdown was quantified and is 
directly correlated to the gene-regulating efficiency of the MCNPs. The greater the GFP 
knockdown, the greater its effect. (e) Schematic of rNSCs undergoing MF with MCNPs 
coated with nucleic acids targeting specific stem cell differentiation. (f) Immunofluorescence 
images showing the differentiation into neurospecific lineages with particular markers, TUJ1 
(neuronal), GFAP (glial cells), and MBP (oligodendrocytes), based on the type of nucleic 
acid delivered. (Reprinted with permission from Ref 38. Copyright 2013 John Wiley and 
Sons)
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FIGURE 4. 
Tracking transplanted stem cells using magnetic resonance imaging (MRI) in vivo. 
Mesenchymal stem cells (MSCs) were loaded with magnetic nanoparticles (MNPs) and 
transplanted into rat brains. The loaded MSCs migrate toward the cortical lesion. (a–c) Time 
course of weighted MRI of rats that were induced with cortical damage. (d) Axial three-
dimensional images showing accumulation of MSCs in the cortex and striatum. (e) 
Enlargement of the white box in (d). Throughout the time period, high-resolution MRI 
revealed that cells migrated along the distant route toward the lesion. The black circles 
represent the location of the induced lesion. White arrows point to MNP-loaded MSCs. 
(Reprinted with permission from Ref 43. Copyright 2008 John Wiley and Sons)
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FIGURE 5. 
Guiding in vivo localization of magnetic nanoparticles (MNPs) using external magnets. (a) 
To demonstrate that MNPs are precisely controlled by the location of a magnetic field, a 
magnet array with spherical patterns was placed underneath a solution of MNPs, and 
resulted in MNPs localizing to locations of highest magnetic strength. (b) To simulate MNPs 
flowing in the bloodstream, a MNP solution passed through the tube with a magnet 
underneath and the localization of the MNP (red) is dictated by the flow rate of the solution. 
(c) MNPs were intravenously injected into the distal portion of the mouse tail vein while a 
magnet was placed at the injection site. High signal in the tail vein of the mice with the 
magnet confirms that localization of MNPs can be externally controlled by a magnet. 
(Reprinted with permission from Ref 46. Copyright 2013 John Wiley and Sons)
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FIGURE 6. 
Silica nanoparticles (SNPs) for tracking stem cells in vivo using ultrasound. (a) Schematic of 
SNPs embedded with FITC for fluorescence imaging and gadolinium for enhancing MRI 
contrast delivered to mesenchymal stem cells (MSCs) and injected into rat heart tissue. (b) 
Ultrasound images of human MSCs (hMSCs) after intracardiac implantation in mice. The 
red arrow represents the bevel of the needle catheter. (c) MRI contract images show 
enhancement of SNP accumulation. (d) Quantification of the MRI and ultrasound (US) 
signal as a function of number of injected SNP-loaded hMSCs. (e) Animals injected (on day 
0, red dot) with hMSCs were monitored sequentially for 12 days postinjection. (Reprinted 
with permission from Ref 56. Copyright 2013 The American Association for the 
Advancement of Science)
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FIGURE 7. 
Mesoporous silica nanoparticles (SNPs) for cell labeling and differentiating induced 
pluripotent stem cells (iPSCs). (a) Positively charged mesoporous SNPs were functionalized 
with an HNF3β-plasmid-DNA (pHNF3β) and delivered to iPSCs. The treated iPSCs showed 
differentiation capacity and differentiated into hepatocyte-like cells with mature functions 
within 2 weeks. (b) Comparing uptake efficiency of different charged mesoporous SNPs 
shows that positively charged SNPs have greatest uptake. (c) Immunofluorescence analysis 
for the expression of hepatic markers HNF3β (green) and HNF4α (red) in iPSCs treated 
with loaded mesoporous SNPs. 1/16 and 1/128 refer to ratios of delivery (scale bar = 200 
μm). (Reprinted with permission from Ref 59. Copyright 2013 American Chemical Society)
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FIGURE 8. 
Fluorescent quantum dots (QDs) for stem cell labeling and tracking. (a) QDs of different 
diameters (top row, nm) and the respective emission wavelength (bottom row, nm) are 
tunable fluorescent probes. (b) QDs incubated in embryonic stem cells (ESCs) show that 
pluripotent makers such as Oct4 remain unaffected. (c) QD-treated ESCs can differentiate 
into three germ layers as evidenced by gene expression of each germ layer. (d) ESCs treated 
with QDs differentiate into germ layers after 4 days. (e–g) Co-culture of QDs-labeled kidney 
stem cells (KSCs) with green fluorescent protein (GFP)-labeled KSCs (green) confirms that 
internalized QDs (red) are not transferred to adjacent cells. (h) Flow cytometry confirms this 
result. (Reprinted with permission from Ref 66.)
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FIGURE 9. 
Embryonic stem cells (ESCs) loaded with quantum dots (QDs) can be simultaneously 
imaged. (a) ESCs were labeled with six different QDs and injected subcutaneously onto the 
backs of nude mice. These labeled ESCs could be imaged with good contrast with a single 
excitation wavelength. (b) Different number of QD-labeled ESCs, 104, 105, and 106, were 
injected into nude mice and signal was quantified and revealed that the signal of ESCs is 
proportional to number of cells injected. (c) To evaluate the clearance properties of labeled 
ESCs, mice were injected with QD-labeled ESCs and longitudinal imaging revealed that the 
QD signal can be detected up to 14 days. (Reprinted with permission from Ref 67. Copyright 
2007 BioMed Central)
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FIGURE 10. 
Nontoxic quantum dots (QDs) for stem cell imaging and delivery of nucleic acids. (a) Novel 
synthesis of ZAIS (Zn, Ag, In, and S) QDs using a sonochemical approach to tune emission 
properties based on the ratio of starting elements. (b) A library of ZAIS QDs synthesized by 
varying elemental composition. (c) Cell viability of novel ZAIS QDs compared to 
conventional CdSe QDs shows that ZAIS QDs are nontoxic to human mesenchymal stem 
cells (hMSCs). (d) ZAIS QDs are effectively internalized by hMSCs and show a strong 
fluorescence signal, thus making ZAIS QDs suitable for stem cell tracking applications. 
(Reprinted with permission from Ref 72. Copyright 2012 John Wiley and Sons)
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FIGURE 11. 
Nanotopography-mediated platform to deliver nucleic acids for stem cell differentiation. (a) 
Silica nanoparticles (SNPs) are assembled on a film and coated with extracellular matrix 
(ECM) proteins and nucleic acids (siRNA) to develop the nanotopography-mediated reverse 
uptake (NanoRU) platform. Neural stem cells (NSCs) cultured on this platform uptake the 
siRNA, which induces their differentiation into neurons. (b) Scanning electron microscopy 
image of neurons (brown) with extended axons cultured on NanoRU wherein the SNPs 
(blue) are visible. (c) Depending on the size of the SNPs on the surface, the uptake rate of 
siRNA is affected, which is reflected by the difference in green fluorescent protein (GFP) 
knockdown. Nanoparticle with 100 nm diameter showed the highest efficiency. (d) 
Fluorescence images showing the differentiation of NSCs into neurons using the NanoRU 
platform, and (e) the expression of the specific markers, Tuj1 (neuronal) and GFAP (glial 
cells), was quantified to reveal that NanoRU is an effective platform to induce stem cell 
differentiation. (Reprinted with permission from Ref 76. Copyright 2013 Nature Publishing 
Group)
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FIGURE 12. 
Axonal alignment and enhanced neural stem cell (NSC) differentiation on graphene–
nanoparticle hybrid substrates. (a) Schematic diagram depicting the influence of 
nanoparticle (NP) monolayers coated with graphene oxide (GO) on the alignment of axons 
extending from human NSCs and their differentiation into neurons. (b–d) Aligned growth 
and extension of axons from differentiated hNSCs, and the compass plots showing the 
variation in the angle of orientation and length of axons. (e) Quantitative gene expression 
results for early- and late-stage neuronal markers expressed by the hNSCs differentiated on 
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the different substrates, with the nanoparticle-hybrid condition having the maximal influence 
on expression of neuron-specific genes. (f) Scheme depicting the significance of alignment 
and growth of axons from differentiating hNSCs. The hNSCs that can be transplanted into 
the injured region (lesion) of a spinal cord differentiate into neurons and glial cells (image 
on right). The axons from the neurons (derived from hNSCs) if aligned can hasten the 
recovery process. Our SiNP–GO hybrid structures can provide the ideal microenvironment 
to align axons that could potentially improve communication leading to rapid recovery of the 
injured spinal cord (image on left). (Reprinted with permission from Ref 77. Copyright 2013 
John Wiley and Sons)
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